Novel Anticonvulsants: An Update on Efficacy
The Carlat Psychiatry Report, Volume 6, Number 2, February 2008
https://www.thecarlatreport.com/newsletter-issue/tcprv6n2/
Issue Links: Learning Objectives | Editorial Information
Daniel Carlat, MD
In this article, we’ll review the clinical data on three of the most frequently used of the novel anticonvulsants: Trileptal (oxcarbazepine), Topamax (topiramate), and Neurontin (gabapentin). We cover Lamictal in this month’s expert interview with Nassir Ghaemi.
You can't view details of this content, please login or buy subscription here
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.